Trialssemaglutideglp-1university of south carolinaobesity

University of South Carolina registers app-based nutrition pilot for GLP-1 patients

The SWITCH intervention gives adults on GLP-1 receptor agonists six weeks of daily dietary self-monitoring and weekly learning modules.

By Priya Raman · Science Reporter

Sep 23 08:00 ETSource: ClinicalTrials.gov

The wire

01NCT07518407, a non-randomized pilot sponsored by the University of South Carolina, is recruiting adults on GLP-1 receptor agonist therapy for obesity or type 2 diabetes, with a start date of April 6, 2026.
02Endpoints are feasibility, acceptability and perceived usefulness, reflecting growing interest in structured nutrition support alongside incretin prescribing.
03It is a pilot with no efficacy endpoint and includes structured interviews at follow-up, so it will not answer whether the app changes weight or glycemic outcomes.

From the source

Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy
NCT07518407 · NA · RECRUITING · Sponsor: University of South Carolina · Conditions: Obesity Type 2 Diabetes Mellitus, Obesity.

Read at clinicaltrials.gov

Source URL https://clinicaltrials.gov/study/NCT07518407